JordanMichaelWinterMD
General Surgery • Cleveland, OHSurgical Oncology (Other than Breast)
Chief of Surgical Oncology, University Hospitals Cleveland Medical Center, Seidman Cancer Center
Dr. Winter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-5777Fax+1 216-844-2888
Summary
- I am a board certified general surgeon, fellowship trained in surgical oncology, with a clinical and research focus in pancreatic and related cancers.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2009 - 2011
Johns Hopkins UniversityResidency, Surgery, 2001 - 2009
Weill Cornell MedicineClass of 2001
Certifications & Licensure
OH State Medical License 2018 - 2025
MA State Medical License 2014 - 2023
PA State Medical License 2011 - 2021
NY State Medical License 2008 - 2012
MD State Medical License 2005 - 2007- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Clinical Trials
- Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer Start of enrollment: 2008 Sep 01
- High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery Start of enrollment: 2016 Apr 27
- CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer Start of enrollment: 2018 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- A Surgeon-Scientist's Pursuit of the Elusive R01.Jordan M Winter, Jonathan R Brody
The Journal of Surgical Research. 2024-11-01 - Leucine-Rich Alpha-2-Glycoprotein 1 Promotes Metastatic Colorectal Cancer Growth Through Human Epidermal Growth Factor Receptor 3 Signaling.Moeez Rathore, Kimberly Curry, Wei Huang, Michel'le Wright, Daniel Martin
Gastroenterology. 2024-10-10 - IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer.Mehrdad Zarei, Omid Hajihassani, Jonathan J Hue, Alexander W Loftus, Hallie J Graor
Cancer Research. 2024-09-16
Grant Support
- Targeting pancreatic cancer's metabolic addiction to HuRNIH2018–2023
- HuR is a critical regulator of pancreatic cancer cell metabolismAmerican Cancer Society2014–2019
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
